Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06434233 · ClinicalTrials.gov registry record · Phase 4

Opioid Use After Laparoscopic Salpingectomy

A Phase 4 study of Opioid Use and Post Operative Pain, sponsored by Johns Hopkins University.

Recruiting
Registry status
Phase 4
Development phase
120
Enrollment target
1
Study location

NCT06434233 is a Phase 4 study of Opioid Use and Post Operative Pain that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 120 participants, below the 148,259-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06434233, a Phase 4 study of Opioid Use and Post Operative Pain, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
Phase 4
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate patient-reported post-operative pain scores following minimally invasive tubal sterilization procedures to determine if a multimodal, non-opioid pain control regimen is non-inferior to a pain control regimen including opioids. The study team hypothesizes that with extensive counseling on pain management, multimodal medication use, and expectation with non-opioid methods can effectively eliminate the need for opioid prescriptions after laparoscopic salpingectomy.

Interventions

  • DRUG Acetaminophen
  • DRUG Ibuprofen
  • DRUG Oxycodone

Study Locations (1)

Maryland

  • Johns Hopkins Bayview Medical Center - Baltimore

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2024-04-25
Est. Completion 2026-11
Phase Phase 4

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT06434233

The ClinicalTrials.gov registry entry for NCT06434233 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 148,259-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Opioid Use appearing as the primary indexed condition, and to 3 interventions - of which Acetaminophen is the first listed.

NCT06434233 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT06434233 about?

NCT06434233 is a clinical study titled "Opioid Use After Laparoscopic Salpingectomy". The purpose of this study is to evaluate patient-reported post-operative pain scores following minimally invasive tubal sterilization procedures to determine if a multimodal, non-opioid pain control regimen is non-inferior to a pain control regimen including opioids. The study team hypothesizes tha...

What is the current status of trial NCT06434233?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2024-04-25. Estimated completion is 2026-11.

What conditions does trial NCT06434233 study?

This clinical trial studies the following conditions: Opioid Use, Post Operative Pain, Sterility, Female.

What interventions are being tested in trial NCT06434233?

The interventions under investigation include: Acetaminophen (DRUG), Ibuprofen (DRUG), Oxycodone (DRUG).

Who is sponsoring clinical trial NCT06434233?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06434233 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.